Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impai
ClinicalTrials.gov study NCT05660395. IPD Sharing: NO. Countries: 4. Publications: 0.
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
ClinicalTrials.gov study NCT06528301. IPD Sharing: NO. Countries: 2. Publications: 0.
Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma
ClinicalTrials.gov study NCT01939730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
ClinicalTrials.gov study NCT07305116. IPD Sharing: NO. Countries: 1. Publications: 0.
Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT03450343. IPD Sharing: NO. Countries: 1. Publications: 0.
Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma
ClinicalTrials.gov study NCT00193505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03851081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.
ClinicalTrials.gov study NCT02964858. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma
ClinicalTrials.gov study NCT06902012. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01854606. IPD Sharing: NO. Countries: 8. Publications: 0.
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
ClinicalTrials.gov study NCT05878184. IPD Sharing: NO. Countries: 2. Publications: 0.
Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab
ClinicalTrials.gov study NCT00561379. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT04628494. IPD Sharing: NO. Countries: 24. Publications: 0.
ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
ClinicalTrials.gov study NCT04043845. IPD Sharing: YES. Countries: 0. Publications: 0.
A Phase I/II Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02957019. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus
ClinicalTrials.gov study NCT00633763. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07199855. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers
ClinicalTrials.gov study NCT04804254. IPD Sharing: NO. Countries: 3. Publications: 0.
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
ClinicalTrials.gov study NCT00003163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT04546620. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.